A genomic classifier predicting metastatic disease progression in men with biochemical recurrence after prostatectomy

A. E. Ross; F. Y. Feng; M. Ghadessi; N. Erho; A. Crisan; C. Buerki; D. Sundi; A. P. Mitra; I. A. Vergara; D. J S Thompson; T. J. Triche; E. Davicioni; E. J. Bergstralh; R. B. Jenkins; R. J. Karnes; E. M. Schaeffer

doi:10.1038/pcan.2013.49

A genomic classifier predicting metastatic disease progression in men with biochemical recurrence after prostatectomy

A. E. Ross, F. Y. Feng, M. Ghadessi, N. Erho, A. Crisan, C. Buerki, D. Sundi, A. P. Mitra, I. A. Vergara, D. J S Thompson, T. J. Triche, E. Davicioni, E. J. Bergstralh, R. B. Jenkins, R. J. Karnes, E. M. Schaeffer

School of Medicine

Research output: Contribution to journal › Article › peer-review

92 Scopus citations

Abstract

Background:Due to their varied outcomes, men with biochemical recurrence (BCR) following radical prostatectomy (RP) present a management dilemma. Here, we evaluate Decipher, a genomic classifier (GC), for its ability to predict metastasis following BCR.Methods:The study population included 85 clinically high-risk patients who developed BCR after RP. Time-dependent receiver operating characteristic (ROC) curves, weighted Cox proportional hazard models and decision curves were used to compare GC scores to Gleason score (GS), PSA doubling time (PSAdT), time to BCR (ttBCR), the Stephenson nomogram and CAPRA-S for predicting metastatic disease progression. All tests were two-sided with a type I error probability of 5%.Results:GC scores stratified men with BCR into those who would or would not develop metastasis (8% of patients with low versus 40% with high scores developed metastasis, P

Original language	English (US)
Pages (from-to)	64-69
Number of pages	6
Journal	Prostate Cancer and Prostatic Diseases
Volume	17
Issue number	1
DOIs	https://doi.org/10.1038/pcan.2013.49
State	Published - Mar 2014

Keywords

biochemical recurrence
clinical validation
genomic classifier
metastasis
prognostic models

ASJC Scopus subject areas

Oncology
Urology
Cancer Research
General Medicine

Access to Document

10.1038/pcan.2013.49

Cite this

Ross, A. E., Feng, F. Y., Ghadessi, M., Erho, N., Crisan, A., Buerki, C., Sundi, D., Mitra, A. P., Vergara, I. A., Thompson, D. J. S., Triche, T. J., Davicioni, E., Bergstralh, E. J., Jenkins, R. B., Karnes, R. J., & Schaeffer, E. M. (2014). A genomic classifier predicting metastatic disease progression in men with biochemical recurrence after prostatectomy. Prostate Cancer and Prostatic Diseases, 17(1), 64-69. https://doi.org/10.1038/pcan.2013.49

Ross, AE, Feng, FY, Ghadessi, M, Erho, N, Crisan, A, Buerki, C, Sundi, D, Mitra, AP, Vergara, IA, Thompson, DJS, Triche, TJ, Davicioni, E, Bergstralh, EJ, Jenkins, RB, Karnes, RJ & Schaeffer, EM 2014, 'A genomic classifier predicting metastatic disease progression in men with biochemical recurrence after prostatectomy', Prostate Cancer and Prostatic Diseases, vol. 17, no. 1, pp. 64-69. https://doi.org/10.1038/pcan.2013.49

@article{c3f5e47d7fc54ddb80e32bdc9a4e5c99,

title = "A genomic classifier predicting metastatic disease progression in men with biochemical recurrence after prostatectomy",

abstract = "Background:Due to their varied outcomes, men with biochemical recurrence (BCR) following radical prostatectomy (RP) present a management dilemma. Here, we evaluate Decipher, a genomic classifier (GC), for its ability to predict metastasis following BCR.Methods:The study population included 85 clinically high-risk patients who developed BCR after RP. Time-dependent receiver operating characteristic (ROC) curves, weighted Cox proportional hazard models and decision curves were used to compare GC scores to Gleason score (GS), PSA doubling time (PSAdT), time to BCR (ttBCR), the Stephenson nomogram and CAPRA-S for predicting metastatic disease progression. All tests were two-sided with a type I error probability of 5%.Results:GC scores stratified men with BCR into those who would or would not develop metastasis (8% of patients with low versus 40% with high scores developed metastasis, P",

keywords = "biochemical recurrence, clinical validation, genomic classifier, metastasis, prognostic models",

author = "Ross, {A. E.} and Feng, {F. Y.} and M. Ghadessi and N. Erho and A. Crisan and C. Buerki and D. Sundi and Mitra, {A. P.} and Vergara, {I. A.} and Thompson, {D. J S} and Triche, {T. J.} and E. Davicioni and Bergstralh, {E. J.} and Jenkins, {R. B.} and Karnes, {R. J.} and Schaeffer, {E. M.}",

year = "2014",

month = mar,

doi = "10.1038/pcan.2013.49",

language = "English (US)",

volume = "17",

pages = "64--69",

journal = "Prostate Cancer and Prostatic Diseases",

issn = "1365-7852",

publisher = "Nature Publishing Group",

number = "1",

}

TY - JOUR

T1 - A genomic classifier predicting metastatic disease progression in men with biochemical recurrence after prostatectomy

AU - Ross, A. E.

AU - Feng, F. Y.

AU - Ghadessi, M.

AU - Erho, N.

AU - Crisan, A.

AU - Buerki, C.

AU - Sundi, D.

AU - Mitra, A. P.

AU - Vergara, I. A.

AU - Thompson, D. J S

AU - Triche, T. J.

AU - Davicioni, E.

AU - Bergstralh, E. J.

AU - Jenkins, R. B.

AU - Karnes, R. J.

AU - Schaeffer, E. M.

PY - 2014/3

Y1 - 2014/3

N2 - Background:Due to their varied outcomes, men with biochemical recurrence (BCR) following radical prostatectomy (RP) present a management dilemma. Here, we evaluate Decipher, a genomic classifier (GC), for its ability to predict metastasis following BCR.Methods:The study population included 85 clinically high-risk patients who developed BCR after RP. Time-dependent receiver operating characteristic (ROC) curves, weighted Cox proportional hazard models and decision curves were used to compare GC scores to Gleason score (GS), PSA doubling time (PSAdT), time to BCR (ttBCR), the Stephenson nomogram and CAPRA-S for predicting metastatic disease progression. All tests were two-sided with a type I error probability of 5%.Results:GC scores stratified men with BCR into those who would or would not develop metastasis (8% of patients with low versus 40% with high scores developed metastasis, P

AB - Background:Due to their varied outcomes, men with biochemical recurrence (BCR) following radical prostatectomy (RP) present a management dilemma. Here, we evaluate Decipher, a genomic classifier (GC), for its ability to predict metastasis following BCR.Methods:The study population included 85 clinically high-risk patients who developed BCR after RP. Time-dependent receiver operating characteristic (ROC) curves, weighted Cox proportional hazard models and decision curves were used to compare GC scores to Gleason score (GS), PSA doubling time (PSAdT), time to BCR (ttBCR), the Stephenson nomogram and CAPRA-S for predicting metastatic disease progression. All tests were two-sided with a type I error probability of 5%.Results:GC scores stratified men with BCR into those who would or would not develop metastasis (8% of patients with low versus 40% with high scores developed metastasis, P

KW - biochemical recurrence

KW - clinical validation

KW - genomic classifier

KW - metastasis

KW - prognostic models

UR - http://www.scopus.com/inward/record.url?scp=84894032450&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84894032450&partnerID=8YFLogxK

U2 - 10.1038/pcan.2013.49

DO - 10.1038/pcan.2013.49

M3 - Article

C2 - 24145624

AN - SCOPUS:84894032450

SN - 1365-7852

VL - 17

SP - 64

EP - 69

JO - Prostate Cancer and Prostatic Diseases

JF - Prostate Cancer and Prostatic Diseases

IS - 1

ER -

A genomic classifier predicting metastatic disease progression in men with biochemical recurrence after prostatectomy

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this